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Abstract The protozoan parasite Entamoeba histolytica con-
tains a second antibacterial protein with lysozyme-like proper-
ties. The newly recognized bacteriolytic protein was purified
from extracts of amoebic trophozoites to allow amino-terminal
sequencing. Subsequent molecular cloning revealed that it is an
isoform of the amoeba lysozyme described previously but also
demonstrated a substantial sequence divergence of the two forms.
As lysozymes typically are basic proteins, the novel amoebic
protein differs markedly in having a pI of 4.5. There is no
significant similarity of both amoeba lysozymes with any
bacteriolytic protein of other organisms reported so far ;
however, striking sequence identity is found with predicted gene
products of unknown function derived from the bacteria-feeding
nematode Caenorhabditis elegans.
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1. Introduction
Antimicrobial systems have been characterized at the mo-
lecular level primarily for vertebrates and arthropods. Despite
the fact that the protozoon Entamoeba histolytica is a human
pathogen and a dramatically active killer of host cells, it may
be viewed also as an insatiable phagocytic cell that inhabits
the lower intestine of man and uses bacteria of the gut as a
nutrient source. The enormous capacity of the amoebae to
phagocytoze bacteria [1] implies that they possess a mecha-
nism by which bacteria can be continually engulfed and then
e⁄ciently killed and degraded. The virtually anaerobic condi-
tions in the lower intestine preclude the possibility that amoe-
bae, like other phagocytes, bring antimicrobial mediators such
as oxygen metabolites and NO into action. Accordingly, E.
histolytica appears to rely on an oxygen-independent principle
(e.g. antibacterial peptides) to combat intracellular microbial
growth within their digestive vacuoles. We were interested to
analyze the molecular antimicrobial armament of this proto-
zoon as a prototype of a primitive phagocytic cell. Until now,
we have isolated from lysosome-like granular vesicles of the
amoebae membrane-active peptides termed amoebapores [2]
as well as a lysozyme-like protein [3]. The latter is a 23-kDa
protein, the molecular mass of which and some mild amino
acid sequence identity (particularly at the N-terminus) placed
it among the Chalaropsis-type rather than among other classes
of lysozyme.
We hypothesized that engulfed bacteria inside the phago-
somes are exposed to an array of antimicrobial factors upon
fusion with the cytoplasmic granules. In a survey for addi-
tional antibacterial peptides, we detected a lysozyme-like ac-
tivity apart from that displayed by the enzyme previously
described [3]. Here, we report the puri¢cation of a second
lysozyme-like protein from trophozoite extracts which after
its N-terminal sequencing and molecular cloning turned out
to be an isoform of the already known amoeba lysozyme and
which has an extraordinarily acidic pI. Since the similarity of
the second isoform to Chalaropsis-type lysozymes is even less
prominent, it is suggested that the amoebic enzymes constitute
a lysozyme class of their own.
2. Materials and methods
2.1. Cultivation and harvesting of E. histolytica
Trophozoites of the E. histolytica isolate HM-1:IMSS were cultured
axenically in medium TYI-S-33 in plastic tissue culture £asks [4].
These amoebae do not represent cloned cells. Trophozoites from cul-
tures in late-logarithmic phase were harvested after being chilled on
ice for 10 min, sedimented at 430Ug for 3 min at 4‡C and washed
three times in ice-cold 20 mM sodium phosphate, 145 mM NaCl, pH
7.4.
2.2. Puri¢cation of amoeba lysozyme II for amino-terminal sequence
analysis
Freshly harvested and washed amoebae (5U108 cells) were ex-
tracted overnight with 5 vol. 10% acetic acid. The extract was centri-
fuged at 150 000Ug at 4‡C for 1 h, and the resulting supernatant was
adjusted with 1 M sodium acetate to pH 4.0. The material was loaded
onto a Resource S cation-exchange column (6 ml; Pharmacia LKB)
equilibrated with 50 mM sodium acetate, pH 4.5. Adsorbed protein
was eluted by washing the column with the same bu¡er (40 ml) and by
use of a 0^500-mM NaCl gradient (120 ml) and a ¢nal wash of 1 M
NaCl. After a second passage over the same column, the £ow-through
containing lysozyme II was dialyzed exhaustively against the starting
bu¡er of the next column in tubing with a molecular mass cut-o¡ of
6000 Da (Spectra/Por 6; Spectrum Industries) and was applied to a
Mono Q HR 5/5 column (Pharmacia LKB) equilibrated with 20 mM
Tris-HCl, pH 7.5. The column was washed with the same bu¡er (5 ml)
and developed with a 25-ml gradient of 0^500 mM NaCl. Active
fractions were pooled and dialyzed against 1 mM sodium phophate,
pH 5.8. This material was subjected to a hydroxyapatite cartridge
(1 ml Econo Pac CHT II; Bio-Rad) equilibrated with the same bu¡er.
Elution was by washing with 1 ml equilibration bu¡er and by use of
linear gradients of 1^10 mM MgCl2 (10 ml) and 1^500 mM sodium
phosphate, pH 5.8 (15 ml). The active 23-kDa protein eluted with
2 mM MgCl2 was subjected to SDS-PAGE and subsequent semi-
dry electroblotting using a poly(vinylidene di£uoride) membrane (Pro-
blott; Applied Biosystems) and analyzed by protein sequencing
using a gas-phase protein sequencer (model 437 A; Applied Bio-
systems).
2.3. Molecular cloning
The cDNA coding for lysozyme I was radiolabelled and used to
screen the HM-1:IMSS cDNA library as described [5]. The method
was modi¢ed by hybridizing the radioactive probe at low stringency
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temperature of 37‡C overnight. The washings were performed in 2U
SSC, 0.1% SDS at 42‡C for 1 h. Cross-hybridizing clones were iso-
lated and the plasmids were released according to the instructions of
the manufacturer (Stratagene). The 5P-ends of all isolated cDNAs
were sequenced [6]. Only cDNAs that di¡ered in their partial nucleo-
tide sequence from the coding sequence of lysozyme I were completely
sequenced on both strands.
2.4. Enzyme assays
For monitoring lysozyme activity during puri¢cation, column frac-
tions were analyzed using the lysoplate technique [7]. Five-Wl samples
were added to wells, 4 mm in diameter, that had been punched into a
plate of 0.9% agarose containing lyophilized M. luteus (0.5 mg/ml;
Sigma) and 50 mM sodium phosphate, pH 6.0. For determination of
the pH for optimal activity, the plates contained 0.1 M citric acid, 0.2
M disodium phosphate in di¡erent ratios (Geigy scienti¢c tables) to
cover a pH range from 2.2 to 7.8. The ionic strength of all bu¡er
mixtures were equalized by adding NaCl. After incubation at 37‡C for
20 h, the diameters of the cleared zones were measured. Chitinolytic
activity was assayed using chitin glycol (Sigma) as a substrate [8].
2.5. Miscellaneous methods
Southern and Northern blotting were performed according to the
published procedures [9]. Blots were preincubated in 0.5 M Na2HPO4,
7% SDS, 1 mM EDTA, pH 7.2 at 50‡C for 1 h and subsequently
hybridized with the radiolabelled cDNA in the same solution and at
the same conditions overnight. The blots were washed twice with 2U
SSC, 0.1% SDS at 20‡C and again at 50‡C for 1 h. For sequence
homology searches, the BlastP 2.0.4 program [10] was used. SDS-
PAGE was performed according to Laemmli [11] with a 13% separa-
tion gel and a 4% stacking gel.
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Fig. 1. Amoeba lysozyme II at di¡erent stages of puri¢cation. Ali-
quots (20 Wl) were subjected to SDS-PAGE under reducing condi-
tions and silver stained. Lane 1: Acidic trophozoite extract; lane 2:
through-£ow of the Resource S column; lane 3: Mono Q fraction;
lane 4: hydroxyapatite fraction. Molecular mass standards are indi-
cated on the left.
Fig. 2. Nucleotide and deduced amino acid sequences of lysozyme II. The N-terminal amino acid sequence obtained by protein sequencing is
underlined. The asterisk represents a stop codon. These data have been deposited with the EMBL, GenBank and DDBJ sequence databanks
and are available under accession number AF034843.
R. Nickel et al./FEBS Letters 437 (1998) 153^157154
3. Results
During puri¢cation of amoeba lysozyme it became apparent
that an additional lysozyme-like activity is present in amoebic
extracts. A crucial step for separation of the two activities was
Resource S cation-exchange chromatography. The majority of
the active material bound to the resin, was eluted at 140 mM
NaCl, and represented the amoeba lysozyme already known
(in the following termed lysozyme I). However, active material
still remained in the £ow-through even after repeated subjec-
tion to the same resin indicating the existence of another
lysozyme-like protein with a considerably less basic character.
The active material of the £ow-through was retained by a
Mono Q anion-exchange column and was eluted at 120^
200 mM NaCl. In activity assays, degradation of M. luteus
cell walls was accompanied by the occurrence of a protein
band of V23 kDa. Puri¢cation to near homogeneity was
achieved by adsorption to hydroxylapatite and elution with
an MgCl2 gradient and ascertained the molecular mass which
is identical to that of lysozyme I (Fig. 1). Puri¢cation using
the aforementioned scheme yielded only minute amounts of
material which, however, were su⁄cient for N-terminal pro-
tein sequencing. The procedure gave sequence information up
to residue 50 (see Fig. 2). A sequence identity of 58% with
lysozyme I revealed that the puri¢ed protein is a second iso-
form, and consequently was named lysozyme II. In the lyso-
plate assay, the pH optimal for activity of lysozyme II was 3.5
in citrate/phosphate bu¡er at a ionic strength of 10 mS. In a
parallel experiment, lysozyme I exerted optimal activity at pH
4.0. As was the case with lysozyme I [3], chitinase activity of
lysozyme II could not be detected (data not shown).
We used the cDNA of lysozyme I to isolate cross-hybridiz-
ing cDNAs coding for lysozyme II. Sequencing of the longest
cDNA insert of 638 bp revealed the complete coding region
for lysozyme II which was preceded by a part of a putative
signal peptide. The mature protein consists of 199 residues
and has a calculated molecular mass of 22 136. The overall
sequence identity between the isoforms is 61% and concerning
amino acids with similar properties at the same position the
similarity is 71%. All four cysteine residues of lysozyme I are
conserved in lysozyme II suggesting two identical disul¢de
connectivities, but lysozyme II possesses three additional cys-
teine residues. The most remarkable di¡erence between the
two isoforms is their isoelectrical point explaining the di¡erent
behavior on the cation exchange column. Whereas lysozyme I
is ^ like most lysozymes ^ a highly basic protein (pI 9.5), the
predicted isoelectrical point at pH 4.5 of lysozyme II is excep-
tionally acidic.
For Southern blot analysis, genomic DNA from tropho-
zoites was digested with several enzymes, for which the lyso-
zyme II gene does not possess restriction sites. Subsequent
hybridization with the lysozyme II cDNA yielded single hy-
bridization fragments in each digest varying in size between
2 and 9 kb (Fig. 3). As probing the blot with lysozyme I at the
same conditions resulted in a markedly di¡erent hybridization
pattern (not shown), cross-hybridization of the two lysozyme
genes could be excluded. The data suggest that lysozyme II is,
like lysozyme I [3], encoded by a single-copy gene. Northern
blot analysis performed with total amoebic RNA revealed
that the probe hybridized to an RNA of W650 bp, which is
in agreement with the expected size of the message (Fig. 3).
A database search for homologue proteins showed no sig-
ni¢cant sequence identities to lysozyme sequences of other
organisms. The highest degree of overall sequence identity
was found to several functionally uncharacterized, putative
gene products of C. elegans (Fig. 4). The putative coding
sequences have been derived from the C. elegans genome proj-
ect [12] and have been predicted by computer analysis using
the program Gene¢nder (Green, P., unpublished) and other
available information. The C. elegans sequences may be di-
vided into two groups of related gene products. f58b3.1,
f58b3.2, f58b3.3 and f17e9.11 are members of the ¢rst group
with 67^81% sequence identities to each other. f17e9.11 is
exceptional among them in that it contains an insertion of
16 amino acid residues. Identities and similarities between
this group and the amoebic lysozymes are, according to Blastp
2.0.4 criteria, 30^38% and 44^58%, respectively. The second
group of putative gene products are af016415, c17g10.5,
y22f5a.a, y22f5a.4 and y22f5a.5 with 48^70% sequence iden-
tities to each other. The overall identities and similarities of
the latter group to the amoebic lysozymes are 24^30% and 43^
49%, respectively. The isoelectrical points of the aforemen-
tioned deduced amino acid sequences of C. elegans were pre-
dicted to be at pH 5.1^6.7, with the exception of f17e9.11,
y22f5a.4 and y22f5a.5 which appear to represent basic pro-
teins with isoelectrical points of 8.2^8.7.
4. Discussion
Lysozymes are bacteriolytic enzymes that have been found
in numerous phylogenetically diverse organisms such as bac-
teria, bacteriophages, fungi, plants and animals [13]. In ani-
mals, they constitute key components of the antibacterial de-
fense. Whereas many of the animals investigated appear to
possess a single type of lysozyme only, multiple forms of
lysozymes can be found when the protein has also been re-
cruited as a digestive enzyme. The latter di¡er in some char-
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Fig. 3. Southern and Northern analysis of lysozyme II. A: Genomic
DNA (10 Wg) prepared from E. histolytica was digested with BglII,
HindII, XmnI and NdeI and hybridized with the cDNA of lysozyme
II. B: Total RNA (10 Wg) of E. histolytica was separated on a
formaldehyde-agarose gel and hybridized with the cDNA of lyso-
zyme II.
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acteristics from conventional lysozymes of birds and mam-
mals, e.g. they have their activity optima at low pH and are
resistant to proteolytic degradation by pepsin [14]. In addi-
tion, these lysozymes are model proteins for adaptive evolu-
tion at the molecular level [14,15].
It is reasonable to assume that the amoebic lysozymes, like
in other phagocytes, are constituents of an intracellular arma-
ment that prevent uncontrolled microbial growth within the
digestive vacuoles and, in addition, ful¢l a digestive function
to exploit bacteria for nutrition. The acidic pH optima of both
isoforms are in agreement with the acidic interior pH in amoe-
bic intracellular vesicles [16]. The two isoforms of amoeba
lysozyme, albeit of virtually identical molecular mass, show
a substantial sequence divergence and, most strikingly, amoe-
ba lysozyme II has an acidic pI. To date, the only lysozyme
known to possess such an acidic pI (4.4) is one of eight iso-
forms from Drosophila melanogaster which is expressed exclu-
sively in the digestive tract and hence presumably has been
recruited as a digestive enzyme [17]. The second isoform de-
scribed here appears to be of relatively low abundance com-
pared to lysozyme I. Since at the moment we were capable of
purifying only minute amounts of lysozyme II from the nat-
ural source, the biochemical comparison of the two isoforms
has to be the subject of future studies using recombinantly
expressed proteins. It is noteworthy that in older studies an-
other amoeboid organism, Hartmanella glebae, was also found
to contain two forms of bacteriolytic proteins, which were
puri¢ed and biochemically classi¢ed as N-acetylmuramidases
[18,19]. One of the two enzymes is produced by Hartmanella
exclusively in response to a particular bacterium [18]. In E.
histolytica, both lysozymes were puri¢ed from amoebae grown
in the absence of bacteria and hence are continuously ex-
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Fig. 4. Amino acid sequence homology of the amoeba lysozymes and functionally uncharacterized sequences of C. elegans. Residues identical
in at least one amoebic lysozyme isoform and one C. elegans sequence are darkly shaded and conserved cysteine residues are in white letters
on a black background; those with similar properties found in both species are lightly shaded. Similar amino acids were de¢ned as follows:
AG; ST; ED; RKH; QN; VILM; YF; W; P; C. Gaps introduced to maximize amino acid alignments are indicated by hyphens. Numbers re-
fer to the positions of the residues at the end of each block in the respective protein. The EMBL/GenBank/DDBJ accession number for lyso-
zyme I is X87610. The accession number for the C. elegans sequences f58b3.1, f58b3.2, f58b3.3 is Z73427. For c17g10.5, af016415 and
f17e9.11, the accession numbers are U28739, AF016415 and AF047656, respectively. The amino acid sequences y22f5a.a, y22f5a.4 and y22f5a.5
share the accession number AL021479.
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pressed, at least at a low level. However, in vivo, i.e. in the
presence of the mixed bacterial £ora of the gut, their amounts
may di¡er.
When we reported previously the primary structure of
amoeba lysozyme I, the ¢rst of protozoan origin, we suggested
its membership to the lysozymes of the Chalaropsis type [3].
Now that we have in addition the primary structure of the
second isoform, the similarity to this distinct class of lyso-
zymes appears even weaker. Notably, only one of two acidic
amino acids considered essential for the catalytic activity of
Chalaropsis lysozyme [20], i.e. the most N-terminal aspartic
acid residue, is found at the same position in both amoebic
lysozymes. This residue is also conserved in the putative pro-
teins of C. elegans. The second critical acidic residue involved
in the catalytic action of most lysozymes may be positioned
di¡erently. Alternatively, one acidic amino acid residue inside
the catalytic cleft might be su⁄cient for bacteriolytic activity
as it is described for goose-type lysozymes [21]. If the C.
elegans sequences are indeed coding for lysozymes, the nem-
atode genome contains at least 9 of such genes. All these
nematode products are much more similar to the amoeba
lysozymes than to those of the Chalaropsis type. The evidence
of their bacteriolytic activity would strengthen our notion that
we are dealing with a novel class of lysozymes, which then
would include the amoeba lysozymes and the putative pro-
teins of the bacteria-feeding nematode.
The enzymes most likely are instrumental in rapid killing
and degradation of engulfed bacteria and may act in synergy
with antibacterial factors such as the amoebapores. The latter
are a family of pore-forming 77-residue-peptides which are
stored also in the cytoplasmic granules. These peptides are
cytolytic and antibacterial by permeating the cytoplasmic
membranes [22]. It is interesting to note that homologs have
been found in lymphocytes of pig [23] and man [24]. Since, in
addition to the lysozymes, numerous sequences of putative
amoebapore-like peptides can be found within the genome
of C. elegans upon a search in databases, it is tempting to
suggest that a common bacteriolytic principle exists in such
phylogenetically diverse organisms as amoebae and nema-
todes.
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